1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Sproutly Canada Inc.

Sproutly Canada Inc.

SPR.CN
Sproutly Canada Inc.CA flagCanadian Securities Exchange
0.02
CAD
- -
- -
7.26MMarket Cap
Sproutly Canada Inc.
SPR.CN
(Canadian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.01
-0.03
-0.02
-0.04
-0.1
-0.3
-0.06
-0.04
Basic EPS, GAAP
-0.02
- -
-0.06
-0.01
-0.06
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
-0.04
-0.01
- -
0.25
-0.02
-0.05
-0.04
Book Value per Share
0.01
-0.02
0.02
0.05
0.02
-0.04
-0.02
-0.01
Tangible Book Value per Share
8
8
8
9
132
205
271
356
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
- -
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
-965.52
-718.2
-298.01
Operating Margin (%)
- -
- -
- -
- -
- -
1
- -
- -
Depreciation Expense
- -
- -
- -
- -
-13
-62
-16
-13
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
-6,646.48
-5,186.69
-2,632.35
Profit Margin (%)
- -
- -
- -
- -
2
-8
-9
-8
Working Capital
- -
- -
- -
- -
9
3
- -
- -
LT Debt
- -
- -
- -
- -
56
4
-6
-5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
May'22
Aug'22
Nov'22
ST Debt
6
7
7
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
359
360
363
Market Capitalization
26
15
14

Working Capital

FRC

•

in mil. unless spec.
May'22
Aug'22
Nov'22
Total Current Assets
2
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
1
- -
Total Current Liabilities
9
9
9
Payables & Accruals
2
2
3
ST Debt
6
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
2,268.5%
-245.32%
Free Cash Flow
- -
635.3%
-83.93%
Net Income, GAAP
- -
766.47%
-73.36%
Sales/Revenue/Turnover
- -
- -
-65.86%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
1
- -
1
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.02
-0.02
-0.01
- -
-0.3
2021
-0.01
-0.01
- -
- -
-0.06
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Similar Companies
Dong-E-E-Jiao Co.,Ltd. (000423.SZ)
Albert David Ltd. (ALBERTDAVD.BO)
Teva Pharmaceutical Industries Limited (TEVA.TA)
Chill Brands Group PLC (CHBRF)
cbdMD, Inc. (YCBD)
Regencell Bioscience Holdings Limited (RGC)
Business
Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to the beverage and consumables markets in Canada. The company offers proprietary natural water-soluble cannabis solutions under the Infuz2O brand and cannabis plant oils infused into bio-natural oils under the BNO brand; these products deliver the whole plant spectrum of natural bioactive molecules using the exclusive APP Technology licensed from Infusion Biosciences in Canada, the EU, UK, Jamaica, Israel, and Australia. It operates a Health Canada-licensed facility in the greater Toronto area for production and cultivation; focuses on partnerships with established consumer brands for marketing, distribution, and co-packing arrangements, including past collaborations with Kingston Cannabis Inc. for cannabis-infused beverages and CMG for edibles; and targets the recreational cannabis segment, including beverages, edibles, and confectionaries such as gummies under the Caliber brand. Founded in 2012 and headquartered in Vancouver, British Columbia, Sproutly pursues innovation in cannabis processing technologies for global markets. In recent developments, the company acquired assets of CannaHive Inc. in August 2021, gaining fully automated pharmaceutical-grade manufacturing equipment for high-quality cannabis confectionaries to enhance scalability and meet Canadian market demand; entered a binding letter of intent with Apollon Formularies to acquire its assets in exchange for shares granting Apollon 49% ownership, with due diligence completed as of late 2021 to support ongoing asset integration; completed a $100,000 private placement financing in August 2022 for general working capital; and faced a management cease trade order in 2022 due to delayed annual financial filings while continuing to trade on the CSE under ticker SPR.CN, OTCQB as SRUTF, and Frankfurt as 38G.